Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance

被引：13

作者：

Negro, Francesco ^{[1
]}

机构：

[1] Univ Geneva, Viropathol Unit, Med Ctr, CH-1211 Geneva, Switzerland

来源：

PPAR RESEARCH | 2009年 / 2009卷

基金：

瑞士国家科学基金会;

关键词：

PPAR-GAMMA; ANTIVIRAL THERAPY; LOW-DENSITY; ALPHA; EXPRESSION; FIBROSIS; GLUCOSE; PIOGLITAZONE; LIVER; CHOLESTEROL;

D O I：

10.1155/2009/483485

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Insulin resistance and type 2 diabetes are associated with hepatitis C virus infection. A wealth of clinical and experimental data suggests that the virus is directly interfering with the insulin signalling in hepatocytes. In the case of at least one viral genotype (the type 3a), insulin resistance seems to be directly mediated by the downregulation of the peroxisome proliferator-activated receptor gamma. Whether and how this interaction may be manipulated pharmacologically, in order to improve the responsiveness to antivirals of insulin resistant chronic hepatitis C, patients remain to be fully explored. Copyright (C) 2009 Francesco Negro.

引用

收藏

页数：6

相关论文

共 46 条

[11] Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis C [J].

Economou, Michael ;

Milionis, Haralampos ;

Filis, Spyridon ;

Baltayiannis, Gerasimos ;

Christou, Leonidas ;

Elisaf, Moses ;

Tsianos, Epameinondas .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (04) :586-591

[12]

Elgouhari HM, 2008, HEPATOLOGY, V48, p383A

[13] Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C [J].

Fartoux, L ;

Poujol-Robert, A ;

Guéchot, J ;

Wendum, D ;

Poupon, R ;

Serfaty, L .

GUT, 2005, 54 (07) :1003-1008

[14] Identification of hepatic transcriptional changes in insulin-resistant rats treated with peroxisome proliferator activated receptor-α agonists [J].

Frederiksen, KS ;

Wulf, EM ;

Wassermann, K ;

Sauerberg, P ;

Fleckner, J .

JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2003, 30 (03) :317-329

[15] Suppression of macrophage inflammatory responses by PPARs [J].

Henson, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) :6295-6296

[16] In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy [J].

Hickman, IJ ;

Powell, EE ;

Prins, JB ;

Clouston, AD ;

Ash, S ;

Purdie, DM ;

Jonsson, JR .

JOURNAL OF HEPATOLOGY, 2003, 39 (06) :1042-1048

[17] Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression [J].

Hui, JM ;

Sud, A ;

Farrell, GC ;

Bandara, P ;

Byth, K ;

Kench, JG ;

McCaughan, GW ;

George, J .

GASTROENTEROLOGY, 2003, 125 (06) :1695-1704

[18] Interferon induces insulin resistance in patients with chronic active hepatitis C [J].

Imano, E ;

Kanda, T ;

Ishigami, Y ;

Kubota, M ;

Ikeda, M ;

Matsuhisa, M ;

Kawamori, R ;

Yamasaki, Y .

JOURNAL OF HEPATOLOGY, 1998, 28 (02) :189-193

[19] Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus [J].

Jay, Mollie A. ;

Ren, Jun .

CURRENT DIABETES REVIEWS, 2007, 3 (01) :33-39

[20] Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARγ agonists [J].

Jiang, GQ ;

Dallas-Yang, Q ;

Li, ZH ;

Szalkowski, D ;

Liu, FL ;

Shen, XL ;

Wu, M ;

Zhou, GC ;

Doebber, T ;

Berger, J ;

Moller, DE ;

Zhang, BB .

DIABETES, 2002, 51 (08) :2412-2419

← 1 2 3 4 5 →